Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 3Phase NA 2Phase 4 2Phase EARLY_PHASE1 1Phase 3 1Phase 1/2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Carcinoma, Hepatocellular 6Solid Cancers 2Melanoma 2Advanced NSCLC 2Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Lung Neoplasms 1Immune-related Adverse Event 1Esophageal Squamous Cell Carcinoma 1EBV-associated Tumors 1Carcinoma, Non-Small-Cell Lung 1Biliary Tract Neoplasms 1Adenocarcinoma Of Esophagus 1

Interventions

Blood Specimen Collection 11Radiosurgery 7Sentinel Lymph Node Biopsy 5Early Intervention, Educational 5Surveys and Questionnaires 4Standard of Care 4Practice Guidelines as Topic 4Methods 4Indocyanine Green 4Educational Status 4X-Rays 3Surgical Procedures, Operative 3Nivolumab 3Magnetic Resonance Spectroscopy 3Ipilimumab 3Immunotherapy 3Cognitive Behavioral Therapy 3Biopsy 3pembrolizumab 2montanide ISA 51 2aldesleukin 2Tomography, X-Ray Computed 2Tomography, Emission-Computed 2Specimen Handling 2Radiotherapy 2Radiation 2Positron-Emission Tomography 2Palliative Care 2Observation 2Interviews as Topic 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Melanoma × Immune Checkpoint Inhibitors × Clear all
NCT07428252 2026-02-25

Gastrointestinal Microbiome and Response to Immunotherapy in Metastatic Malignant Melanoma

Institute of Oncology Ljubljana

Phase NA Active not recruiting
150 enrolled
Dermatologic

Melanoma

NCT05878977 2024-10-18

Biomarkers in Immunotherapy of Melanoma

Institute of Oncology Ljubljana

Phase NA Recruiting
150 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡